公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection | CHEN-HUA LIU ; HSIN-YUN SUN ; CHUN-JEN LIU ; WANG-HUEI SHENG ; SZU-MIN HSIEH ; Lo Y.-C; Liu W.-C; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 25 | 21 | |
2003 | Genetic alterations in hepatocellular adenomas [3] (multiple letters) | Bioulac-Sage P.; Laurent-Puig P.; Balabaud C.; Zucman-Rossi J.; Chen Y.-W.; YUNG-MING CHEN ; Shiou-Hwei Yeh ; PEI-JER CHEN | Hepatology | 8 | 9 | |
2008 | Genetic analysis and evaluation of the reassortment of influenza B viruses isolated in Taiwan during the 2004-2005 and 2006-2007 epidemics | Jian J.-W.; Lai C.-T.; Kuo C.-Y.; Kuo S.H.-S.; Hsu L.-C.; PEI-JER CHEN ; Wu H.-S.; Liu M.-T. | Virus Research | 23 | 18 | |
2008 | Genetic and epidemiological analysis of influenza virus epidemics in Taiwan during 2003 to 2006 | Jian J.-W.; Chen G.-W.; Lai C.-T.; Hsu L.-C.; PEI-JER CHEN ; Kuo S.H.-S.; Wu H.-S.; Shih S.-R. | Journal of Clinical Microbiology | 24 | 22 | |
2006 | Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma | Shiou-Hwei Yeh ; Wu D.-C.; Tsai C.-Y.; Kuo T.-J.; Yu W.-C.; Chang Y.-S.; CHI-LING CHEN ; Chang C.-F.; Chen D.-S.; PEI-JER CHEN | Clinical Cancer Research | 54 | 49 | |
2008 | The genetic differences with whole genome linkage disequilibrium mapping between responder and non-responder in interferon-α and ribavirin combined therapy for chronic hepatitis C patients | PEI-JER CHEN ; Hwang Y.; Lin C.G.-J.; Wu Y.-J.; Wu L.S.-H. | International Journal of Immunogenetics | 4 | 4 | |
2006 | Genetic mutation in hepatic adenoma: Seeing is believing | PEI-JER CHEN | Journal of Hepatology | 9 | 8 | |
2002 | Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study | King J.K.; Shiou-Hwei Yeh ; Lin M.-W.; CHUN-JEN LIU ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Hepatology | 63 | 54 | |
2006 | Genetic predisposition of responsiveness to therapy for chronic hepatitis C | Hwang Y.; Chen E.Y.; Gu Z.J.; Chuang W.-L.; Yu M.-L.; Lai M.-Y.; Chao Y.-C.; Lee C.-M.; Wang J.-H.; Dai C.-Y.; Bey M.S.-J.; Liao Y.-T.; PEI-JER CHEN ; Chen D.-S. | Pharmacogenomics | 26 | 23 | |
2006 | Genetic structural differences between responders and non-responders to interferon therapy for chronic hepatitis-B patients | PEI-JER CHEN ; Lin C.G.-J.; Lin F.Y.-F.; Chen E.; Wu L.S.-H. | Journal of Human Genetics | 6 | 3 | |
2005 | Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: Synergism between IL-10 genotype of patient and IL-10 receptor β genotype of donor | Lin M.-T.; Storer B.; Martin P.J.; LI-HUI TSENG ; Grogan B.; PEI-JER CHEN ; Zhao L.P.; Hansen J.A. | Blood | 68 | 60 | |
2017 | Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma | Lin Y.-Y.; MING-WHEI YU ; Lin S.-M.; Lee S.-D.; CHIH-LING CHEN ; DING-SHINN CHEN ; PEI-JER CHEN | Cancer | 20 | 17 | |
2010 | A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese | Tsai, Fuu-Jen; Yang, Chi-Fan; Chen, Ching-Chu; LEE-MING CHUANG ; Lu, Chieh-Hsiang; Chang, Chwen-Tzuei; Wang, Tzu-Yuan; Chen, Rong-Hsing; Shiu, Chiung-Fang; Liu, Yi-Min; Chang, Chih-Chun; PEI-JER CHEN ; Chen, Chien-Hsiun; Fann, Cathy S J; Chen, Yuan-Tsong; Wu, Jer-Yuarn | PLoS genetics | 287 | 276 | |
2017 | Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers | Kao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; CHUN-JEN LIU ; Huang C.-J.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; MING-WHEI YU | Molecular Carcinogenesis | 20 | 16 | |
2002 | Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Clinical Microbiology | 176 | 156 | |
1995 | Genotypes of hepatitis C virus in taiwan and the progression of liver disease | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; PEI-MING YANG ; JIN-CHUAN SHEU ; Wang T.-H.; DING-SHINN CHEN | Journal of Clinical Gastroenterology | 62 | 56 | |
2004 | Genotypic Dominance and Novel Recombinations in HBV Genotype B and C Co-Infected Intravenous Drug Users | Chen B.-F.; JIA-HORNG KAO ; CHUN-JEN LIU ; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Medical Virology | 44 | 38 | |
2020 | Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment | CHEN-HUA LIU ; Yang S.-S.; Peng C.-Y.; Lin W.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Viral Hepatitis | 20 | 20 | |
2020 | Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; CHIEN-CHING HUNG ; SZU-MIN HSIEH ; TUNG-HUNG SU ; HSIN-YUN SUN ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | 21 | 20 | |
2015 | Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study | Park J.-W.; Chen M.; Colombo M.; Roberts L.R.; Schwartz M.; PEI-JER CHEN ; Kudo M.; Johnson P.; Wagner S.; Orsini L.S.; Sherman M. | Liver International | 779 | 694 | |